Liver transplantation in a patient after COVID-19 - Rapid loss of antibodies and prolonged viral RNA shedding.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2021 Apr

filter terms:

To date, little is known about the duration and effectiveness of immunity as well as possible adverse late effects after an infection with SARS-CoV-2. Thus it is unclear, when and if liver transplantation can be safely offered to patients who suffered from COVID-19. Here, we report on a successful liver transplantation shortly after convalescence from COVID-19 with subsequent partial seroreversion as well as recurrence and prolonged shedding of viral RNA. © 2020 The Authors. American Journal of Transplantation published by Wiley Periodicals LLC on behalf of The American Society of Transplantation and the American Society of Transplant Surgeons.

Citation

Hanno Niess, Nikolaus Börner, Maximilian Muenchhoff, Elham Khatamzas, Manfred Stangl, Alex Graf, Philipp Girl, Enrico Georgi, Dionysios Koliogiannis, Gerald Denk, Michael Irlbeck, Jens Werner, Markus Guba. Liver transplantation in a patient after COVID-19 - Rapid loss of antibodies and prolonged viral RNA shedding. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2021 Apr;21(4):1629-1632